Caucasians, Africans and Amerindians 3 , the prevalence of MS is less than 15 cases per 100,000 inhabitants in Sao Paulo City 4 and about 20,100,000 inhabitants in Rio de Janeiro City 5 . The genetic components of MS pathogenesis are quite complex 6 , and the human leukocyte antigen (HLA) class II genes (6p21.3) appear to play an important role in determining the risk for MS. For example, the HLA-DRB1*15:01 allele is consistently associated with MS 6 . Studies performed on North American and European populations revealed an association between the HLA-DRB1*15:01, -DQA1*01:02 and -DQB1*06:02 alleles and the development of MS 7 , and these alleles have also been linked to MS in the Brazilian population 8, 9, 10 . In particular, a previous Brazilian study showed that the DRB1*15:01 allele confers ethnicity-dependent MS susceptibility in Caucasian patients, whereas that the DQB1*06:02 allele confers genetic susceptibility regardless of ethnicity 8 . In addition, the HLA-DRB1*15 allelic group has been associated with MS in samples from Brazil 9 and Portugal 11, 12 , the European country that originally colonized Brazil.
Studies have also searched for non-MHC genetic risk factors for MS, and CIITA (also called MHC2TA, loci 16p13) polymorphisms have been reported as putative susceptibility factors 13, 14 . In fact, CIITA is an attractive candidate molecule in studies involving a variety of autoimmune diseases and inflammatory HLAassociated conditions 13, 14, 15 . Furthermore, expression of MHC II is tightly controlled by the class II transactivator, which is a master regulator of both constitutive and inducible MHC II expression 16 . The goal of this study was to investigate the association between a large number of polymorphic alleles and MS in a sample from Rio de Janeiro State, Brazil. In particular, we analyzed 84 polymorphic alleles, including the HLA DQA1, DQB1 and DRB1 loci, as well as the CIITA polymorphisms -168A/G and +1614 G/C. In addition, we searched for gender-related differences in the associations between MS and these polymorphisms.
METHOD

Patients and controls
Peripheral blood samples were taken from 52 relapsingremitting MS (RRMS) patients [35 females (67.3%); 17 males (32.7%)] who had been diagnosed with MS and were registered with the outpatient clinic of neurology at the University Hospital Clementino Fraga Filho (UFRJ). All the patients fulfill magnetic resonance imaging (MRI) criteria for distribution in space and time 17 . Blood samples were also taken from 126 healthy control subjects [ 17 . The Afro-Brazilians were classified in this ethnic group if they could not identify White ancestry for up to three generations time period. This criteria was accepted in our previous studies ethnicity-dependent 8 .
DNA Typing
DNA was extracted from the blood samples using the organic method, and the HLA-DRB1 (Table 1) , HLA-DQB1 (Table 2) and HLA-DQA1 (Table 3) alleles were identified by PCR amplification with sequence-specific primers using the One Lambda (Canoga Park, CA, USA) kit, according to the manufacturer's recommendations. Sequencing of the single nucleotide polymorphisms (SNPs) +1614G/C (rs4774*C; G500A) and -168A/G (rs3087456) within CIITA was performed using PCR, as described by Patarroyo et al. 18 , followed by capillary electrophoresis on the ABI PRISM ® 3500 Genetic Analyzer (Applied Biosystems, Foster City, CA) platform to identify the genetic profiles in the patient and control groups.
Statistical analysis
The relative frequencies of the alleles were manually calculated. The p-values and odds ratio (OR) were calculated using the Epi Info, a public-domain software program created by the CDC (Centers for Disease Control and Prevention), and SPSS Statistics software.
Ethics
All patients were duly informed with respect to the use of their clinical and genetic data in accordance with the study protocol, which was approved by the institution's Internal Review Board. 
RESULTS
We investigated the association between MS susceptibility and 84 alleles of the polymorphic HLA-Class II genes: 49 from the DRB1 locus, 25 from the DQB1 locus and 10 from the DQA1 locus (Tables 1, 2 and 3) . To the best of our knowledge, this is the most comprehensive survey of the association between genetic polymorphisms and MS that has been conducted on a Brazilian population.
We observed that the OR related to MS associated with HLA-DRB1*15:01 was 3.52. In addition, the association between MS and HLA-DRB1*15:01 was only significant in female patients: 31.43% of female patients had the allele (OR = 4.78; p = .001), whereas only 23.53% of male patients had the allele (OR = 2.05; p = .16) ( Table 4) .
We did not find a significant association between the CIITA polymorphism rs3087456 and susceptibility to MS. The data related to the rs4774 CIITA polymorphism are shown in Table 4 . We observed that the CIITA polymorphism rs4774 (+1614G/C) in combination with HLA-DRB1*15:01 increased the OR to 2.65 (p = .005). Table 5 shows our gender analyses. In particular, females carrying both the rs4774*C and DRB1*15:01 alleles had an OR of 4.55 (p = .02). 
DISCUSSION
Systematic molecular genetic studies have provided important insights into MS susceptibility. In particular, the association between HLA-class II genes and the relative risk for MS has been investigated in several populations 1, 6, 9 , and a link between HLA-DRB1* and MS susceptibility in Brazilian patients has already been reported 19 
.
In our sample, which was taken from Rio de Janeiro State in Southeast Brazil, HLA-DRB1*15:01 was observed to be a genetic susceptibility factor for MS. However, the significant association between DRB1*15:01 and MS was female-specific (Table  4) , consistent with previous reports based on different populations 20, 21 . Indeed, women are twice as likely as men to develop MS, and this disparity has been increasing for at least 50 years in certain populations 2 . This phenomenon can be partly explained by genetic interactions between polymorphisms in the estrogen receptor (ER) 21 and Vitamin D receptor (VDR) genes 22 and the HLA-DRB1*15:01 allele, which increase the risk for MS 21 . Furthermore, the DRB1*15:01 allele was previously shown to be over-represented within Brazilian patients 9 , and it was associated with both younger age at diagnosis and with being female; however, no association was observed between DRB1*15:01 and disease course 23 . It has been reported that, in general, African-Brazilian patients (e.g., from Rio de Janeiro) possess certain Europeanderived alleles, such as HLA-DQB1*06:02, but do not possess the DRB1*15:01 allele, which is more common in Brazilian Caucasians, African Americans and Europeans. The HLA-DRB1*15:01-DQB1*06:02 association was already identified as a susceptibility factor for MS in Caucasian Brazilian samples 8 . Unlike previous studies conducted on Brazilian populations 8, 24 , we did not observe an association between the HLA-DQA1*02:01-03:01 alleles and MS (Table 3 ). In addition, an association between HLA-DQB1*06:02 and MS in the absence of DRB1*15:01 was not observed in patients of African descent, which also does not agree with previous studies 10 . These inconsistent results may be due to differences in the ethnic admixtures of the analyzed population samples.
Although MS is considered to be rare in Brazil, the significant number of affected Brazilians of African descent has drawn the attention of researchers because this ethnic group is rarely affected by MS in other countries 25 . The fact that such a phenomenon is observed in Brazil could be attributed to the degree of ethnic admixing among the local population 10 . In a recent genome-screening survey, several novel loci were identified that showed significant associations with MS outcome, including IL2RA, IL7RA, CLEC16A, CD58, TNFRSFA1 and IRF8
27
, the majority of which are located near genes with immune functions or that have been associated with other autoimmune diseases. The CIITA gene is a known regulator of HLA-D expression and is found within the CLEC16A-SOCS1-CIITA gene complex 28 , a chromosomal region that has been associated with susceptibility to MS 28, 29 . An association between the rs4774*C missense variant and susceptibility to MS -as well as to other autoimmune diseases, such as lupus erythematous -has been previously described 13 . Bronson et al.
13
, using a European data set of 1,320 MS cases, identified an association between the missense mutation +1614G/C (rs4774) and the HLA-DRB1*15:01 allele as a risk factor for MS in Caucasian European groups 13 . In contrast, earlier studies investigating the association between the +1614G/C mutation and MS did not find a significant association
30
. We also note that previous studies involving the rs3087456 variant of CIITA presented conflicting results 13 . In a study of a Nordic population, the authors observed significant differences in rs3087456 frequencies between MS patients and the healthy control group 30 , although another case-control study found no significant differences with respect to this mutation between patients and control groups in Northern Ireland. In addition, Ramagoplan et al. 22 failed to identify a relationship between CIITA variants and MS types in a Canadian population. However, in a sample group taken from Rio de Janeiro, Brazil, we found that a combination of the +1614G/C (rs4774) mutation and the HLA-DRB1*15:01 allele increased susceptibility to MS and that the HLA-DRB1*15:01-MS association was stronger in female patients (Table 4 ). These findings reinforce the multifactorial and polygenic nature of MS.
In conclusion, our results indicated that the HLA-DRB1*15:01 allele was associated with susceptibility to MS in a sample population from Rio de Janeiro, Brazil. Furthermore, this association was more significant in female patients. Therefore, we conclude that the rs4774*C mutation in combination with the HLA-DRB1*15:01 allele increases susceptibility to MS in this population.
